Editorial: A Time of Transition of Alzheimer's Disease in the Advent of Anti-Amyloid Monoclonal Antibodies

被引：5
作者：
Tousi, Babak [1 ]
Sabbagh, Marwan Noel [2 ]
机构：
[1] Cleveland Clin, Ctr Brain Hlth, Cleveland, OH 44106 USA
[2] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, 888 W Bonneville Ave, Las Vegas, NV 89106 USA
来源：
NEUROLOGY AND THERAPY | 2021年 / 10卷 / 02期
关键词：
Monoclonal antibodies; Aducanumab; Disease-modifying treatments; Alzheimer's disease; Mild cognitive impairment; MILD COGNITIVE IMPAIRMENT; DEMENTIA; QUESTIONNAIRE;
D O I：
10.1007/s40120-021-00286-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：409 / 413
页数：5
相关论文
共 13 条
  • [1] Critical Appraisal of Amyloid Lowering Agents in AD
    Decourt, Boris
    Boumelhem, Fadel
    Pope, Evans D., III
    Shi, Jiong
    Mari, Zoltan
    Sabbagh, Marwan Noel
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2021, 21 (08)
  • [2] MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN
    FOLSTEIN, MF
    FOLSTEIN, SE
    MCHUGH, PR
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) : 189 - 198
  • [3] Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study
    Kivipelto, Miia
    Ngandu, Tiia
    Laatikainen, Tiina
    Winblad, Bengt
    Soininen, Hilkka
    Tuomilehto, Jaakko
    [J]. LANCET NEUROLOGY, 2006, 5 (09) : 735 - 741
  • [4] The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment
    Nasreddine, ZS
    Phillips, NA
    Bédirian, V
    Charbonneau, S
    Whitehead, V
    Collin, I
    Cummings, JL
    Chertkow, H
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : 695 - 699
  • [5] Mild cognitive impairment as a diagnostic entity
    Petersen, RC
    [J]. JOURNAL OF INTERNAL MEDICINE, 2004, 256 (03) : 183 - 194
  • [6] Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
    Rabinovici, Gil D.
    Gatsonis, Constantine
    Apgar, Charles
    Chaudhary, Kiran
    Gareen, Ilana
    Hanna, Lucy
    Hendrix, James
    Hillner, Bruce E.
    Olson, Cynthia
    Lesman-Segev, Orit H.
    Romanoff, Justin
    Siegel, Barry A.
    Whitmer, Rachel A.
    Carrillo, Maria C.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (13): : 1286 - 1294
  • [7] Comparison of 2 Informant Questionnaire Screening Tools for Dementia and Mild Cognitive Impairment AD8 and IQCODE
    Razavi, Mehrdad
    Tolea, Magdalena I.
    Margrett, Jennifer
    Martin, Peter
    Oakland, Andrew
    Tscholl, David W.
    Ghods, Sarah
    Mina, Mazdak
    Galvin, James E.
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2014, 28 (02) : 156 - 161
  • [8] Increasing Precision of Clinical Diagnosis of Alzheimer's Disease Using a Combined Algorithm Incorporating Clinical and Novel Biomarker Data
    Sabbagh M.N.
    Lue L.-F.
    Fayard D.
    Shi J.
    [J]. Neurology and Therapy, 2017, 6 (Suppl 1) : 83 - 95
  • [9] The Alzheimer's Questionnaire: A Proof of Concept Study for a New Informant-Based Dementia Assessment
    Sabbagh, Marwan N.
    Malek-Ahmadi, Michael
    Kataria, Rahul
    Belden, Christine M.
    Connor, Donald J.
    Pearson, Caleb
    Jacobson, Sandra
    Davis, Kathryn
    Yaari, Roy
    Singh, Upinder
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2010, 22 (03) : 1015 - 1021
  • [10] Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval
    Tolar, Martin
    Abushakra, Susan
    Hey, John A.
    Porsteinsson, Anton
    Sabbagh, Marwan
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
12